Medical Equipment

Buccal Drug Delivery System Market Expansion to $5.88 Billion by 2029: Key Drivers and Trends

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the buccal drug delivery system market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Buccal Drug Delivery System Market Today And What Will It Reach By 2029?

The buccal drug delivery system market has shown robust expansion in recent years. Its size is expected to climb from $3.55 billion in 2024 to $3.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.5%. The notable growth observed in prior periods stems from early innovations in drug delivery, widespread adoption by the pharmaceutical industry, successful clinical studies demonstrating efficacy, effective market penetration strategies, and the development of applications for specific diseases.

The buccal drug delivery system market size is poised for substantial expansion over the next few years. It is forecast to increase to $5.88 billion by 2029, achieving a compound annual growth rate (CAGR) of 10.9%. This projected growth can be ascribed to several factors, including patient-centric drug delivery methods, an expanding geriatric demographic, the increasing need for targeted therapies, the delivery of biologics and peptides, supportive regulatory environments and approvals, and heightened investments in research and development. Significant developments anticipated during this period involve enhanced patient convenience and compliance, innovations in drug formulations, the rising incidence of chronic diseases, specialized care for pediatric and geriatric populations, and improved bioavailability of drugs.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp

What Factors Are Boosting The Buccal Drug Delivery System Market?

The increasing occurrence of chronic diseases is anticipated to propel the future expansion of the buccal drug delivery systems market. Chronic diseases are ailments that persist for a year or longer, encompassing conditions such as cancer, heart disease, stroke, diabetes, cancer, and arthritis. These are prevalent chronic illnesses that, while manageable, cannot be cured and thus necessitate continuous nutritional and medical attention. Buccal drug delivery systems offer an appropriate and effective method for administering mucosal and transmucosal drugs, which are essential for many patients suffering from chronic diseases like diabetes and cancer. For instance, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths globally, representing 74% of the total, were annually caused by non-communicable diseases (NCDs) or chronic diseases. Specifically, cardiovascular diseases were responsible for 17.9 million deaths, cancer for 9.3 million deaths, chronic respiratory diseases for 4.1 million deaths, and diabetes for 2.0 million deaths. Therefore, the rising prevalence of chronic diseases is a driving force behind the growth of the buccal drug delivery systems market.

How Is The Buccal Drug Delivery System Market Categorized By Application, Type, And Region?

The buccal drug delivery systemmarket covered in this report is segmented –

1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays

2) By Application: Pain Management, Smoking Cessation, Angina Pectoris

3) By End-User: Hospitals, Ambulatory Centers, Other End-Users

Subsegments:

1) By Sublingual: Sublingual Tablets, Sublingual Films

2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges

3) By Oral Sprays: Spray Solutions, Spray Gels

How Are Technological Trends Affecting The Buccal Drug Delivery System Market Growth?

Leading companies in the buccal drug delivery systems market are focusing on developing innovative solutions, such as oral treatments for plaque psoriasis, to improve patient outcomes and enhance the efficacy of drug delivery. Oral treatment for plaque psoriasis refers to the administration of medications taken by mouth to manage and alleviate the symptoms of this chronic autoimmune condition, characterized by the rapid growth of skin cells leading to thick, red, scaly patches. For instance, in September 2022, Bristol Myers Squibb, a US-based pharmaceutical company, received FDA approval for Sotyktu (deucravacitinib), an oral treatment for adults with moderate-to-severe plaque psoriasis. This approval marks the first new oral therapy for this condition in nearly a decade, offering a novel mechanism of action as a selective inhibitor of tyrosine kinase 2 (TYK2).

Who Are The Global Leaders Steering The Buccal Drug Delivery System Market Forward?

Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca PLC, F Hoffmann-La Roche Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Buccal Drug Delivery System Market?

North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8290&type=smp

Browse Through More Reports Similar to the Global Buccal Drug Delivery System Market 2025, By The Business Research Company

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Implantable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Injectable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795